In conclusion, the pivotal function of the NF-κB pathway in GBM proliferation and therapeutic resistance suggests that a comprehensive understanding of the regulation of this transcription factor in GBM could markedly enhance the effective management of these tumors. The gene discussed is NFKB1; the disease is glioblastoma.